The use of lipid nanoparticles (LNPs) in BioNTech/Pfizer and Moderna COVID-19 mRNA vaccines.
The Brilacidin trial for the treatment of COVID-19 infection has started in February 2021 and is expected to be completed in July 2021.
The Development History of Tamiflu Oseltamivir
API is a compound that can be safely used in the human body for therapeutic diagnosis after sufficient pharmaceutical research. The pharmaceutical intermediate is a compound in the process of…
This article gives you information about antidiabetic drugs classification and their mechanism of action.
Baloxavir marboxil, marketed as Xofluza, is a first-in-class, one-dose oral agent first approved by the FDA in 2018 for the treatment of acute, uncomplicated influenza in individuals 12 years…